Frontlight ResearchEarly access
Trial site
Pantai Hospital Kuala Lumpur
- 7running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Metastatic breast cancer3 trials
- Triple-negative breast cancer2 trials
- Head and neck cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 37 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Suspended1 trial
- Lead sponsor
- Gilead Sciences3 trials
- Janssen Research & Development, LLC3 trials
- Amgen1 trial
- Celcuity Inc1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Site data: ClinicalTrials.govUpdated 18 Nov 2026